Durba Gangulya,
Chetan Kumar Jainbc,
Ramesh Chandra Santraa,
Susanta Roychoudhuryb,
Hemanta Kumar Majumderc and
Saurabh Das*a
aDepartment of Chemistry (Inorganic Section), Jadavpur University, Kolkata-700 032, India. E-mail: sdas@chemistry.jdvu.ac.in; Tel: +91 89 02087756
bCancer Biology & Inflammatory Disorder Division, Indian Institute of Chemical Biology, Kolkata-700 032, India
cInfectious Diseases and Immunology Division, Indian Institute of Chemical Biology, Kolkata-700 032, India
First published on 4th January 2017
Correction for ‘The biological in vitro effect and selectivity shown by a CoII complex of 2-(2-hydroxyphenylazo)-indole-3′-acetic acid on three distinctly different cancer cells’ by Durba Ganguly et al., RSC Adv., 2016, 6, 114906–114915.
Cell lines used | cis HPIA | trans HPIA | CoII(HPIA)2 | Cisplatin |
---|---|---|---|---|
HEK293T | 69.22 ± 5.80 | 53.98 ± 1.42 | 44.82 ± 1.45 | 2.6–8.3 (ref. 50 and 51) |
HCT116 | 30.05 ± 3.64 | 29.94 ± 4.49 | 15.6 ± 2.08 | 5.4–7.4 (ref. 52 and 53) |
MOLT-4 | 29.78 ± 1.10 | 24.92 ± 3.65 | 18.63 ± 1.08 | 0.3–1.3 (ref. 54 and 55) |
MCF-7 | 37.66 ± 3.61 | 38.63 ± 4.01 | 23.61 ± 1.16 | 15.0–20.0 (ref. 56 and 57) |
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2017 |